Hepion Pharmaceuticals, Inc.
HEPA
$0.06
-$0.03-35.23%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.63M | 2.60M | 1.83M | 2.32M | 2.92M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 298.80K | 102.90K | 1.24M | 1.42M | 1.58M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.93M | 2.71M | 3.07M | 3.74M | 4.51M |
|
|
|||||
| Total Current Assets | 1.93M | 2.71M | 3.07M | 3.74M | 4.51M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.93M | 2.71M | 3.07M | 3.74M | 4.51M |
|
|
|||||
| Total Accounts Payable | 169.90K | 138.40K | 167.80K | 77.20K | 172.70K |
| Total Accrued Expenses | 322.90K | 347.10K | 77.50K | 55.90K | 48.50K |
| Short-term Debt | -- | -- | 54.10K | 214.30K | 371.70K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 250.00K | -- | -- | -- |
| Total Other Current Liabilities | -- | 250.00K | -- | -- | -- |
| Total Current Liabilities | 492.80K | 735.60K | 299.40K | 347.40K | 592.90K |
|
|
|||||
| Total Current Liabilities | 492.80K | 735.60K | 299.40K | 347.40K | 592.90K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 54.10K | 214.30K | 371.70K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 156.20K | 113.20K | 103.00K | 68.40K | 115.70K |
| Total Liabilities | 648.90K | 848.70K | 402.40K | 415.80K | 708.50K |
|
|
|||||
| Common Stock & APIC | 247.73M | 247.06M | 247.06M | 247.06M | 247.06M |
| Retained Earnings | -248.16M | -246.91M | -246.10M | -245.44M | -244.97M |
| Treasury Stock & Other | 8.30K | 8.30K | 8.30K | 8.30K | 8.30K |
| Total Common Equity | -416.60K | 161.60K | 972.40K | 1.63M | 2.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.70M | 1.70M | 1.70M | 1.70M | 1.70M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.70M | 1.70M | 1.70M | 1.70M | 1.70M |
|
|
|||||
| Total Common Equity | -416.60K | 161.60K | 972.40K | 1.63M | 2.10M |
| Total Preferred Equity | 1.70M | 1.70M | 1.70M | 1.70M | 1.70M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.28M | 1.86M | 2.67M | 3.32M | 3.80M |
|
|
|||||